Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

NCT04037241 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor terminated

Conditions

Malignant Tumor of Pancreas Metastatic to Liver

Interventions

BIOLOGICAL: Anti-CEA CAR-T cells
DRUG: gemcitabine/nab paclitaxel
DRUG: NLIR+FU/FA
DRUG: Capecitabine

Sponsor

Sorrento Therapeutics, Inc.